OpenAI unveils GPT-Rosalind to surface new drug leads for neurodegenerative diseases

gdb · x · 2026-11-21

OpenAI, together with perturbaitx and Scripps Research, announced GPT-Rosalind, showing how AI helps scientists uncover new leads for understanding and treating neurodegenerative diseases, along with the brain research behind the collaboration. Greg Brockman amplified the announcement.

Related event: OpenAI Unveils GPT-Rosalind for Neurodegenerative Drug Discovery(2 posts)→

Original post →

More from Research

Research channel →